Rarity Bioscience
PrivateLast Round
VC Round
Jun 18, 2024
Total Funding Raised
$3.22M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Rarity Bioscience is a biotechnology company that provides ultra-sensitive multiplex assays for mutation detection in liquid biopsies for research and clinical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rarity Bioscience Comparables
Compare Rarity Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pillar Biosciences | 77% | |
| AccuraGen | 76% | |
| Sysmex Corporation | 76% |
Rarity Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 18, 2024 | ||||
| Seed | Feb 6, 2023 | ||||
| Angel | Jul 12, 2021 |
Key People
Founding team and executive leadership
Rarity Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Navigare Ventures | Seed, VC Round |
| Uppsala University Invest | Angel, VC Round, Seed |
| Novalis Biotech | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 121% MoM, reaching 1.5K.
- Sep 9, 2025
Presented at the ADLM 2025 event, featuring CEO Linus Bosaeus.
Recent news
Latest coverage and updates
- is_developingOct 6, 2026
Rarity Bioscience AB further develops the superRCA method
- recognized_asSep 30, 2026
Rarity Bioscience AB wins the CYTO 2026 Innovation Technology Showcase
- launchesSep 17, 2026
Rarity Bioscience AB launched superRCA Ultra-Sensitive KIT D816V Kit RUO on Sep 17th '26.
Rarity Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rarity Bioscience's valuation, stock price, and market status.
Is Rarity Bioscience a public or private company?
Rarity Bioscience is a private company.
What is the current stock price of Rarity Bioscience?
Rarity Bioscience is a private company, so its shares have no public market price. Caplight tracks Rarity Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rarity Bioscience worth (valuation)?
Valuation information for Rarity Bioscience is not publicly available.
Can I buy Rarity Bioscience stock?
Rarity Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rarity Bioscience's last funding round?
Rarity Bioscience's most recent funding round was VC Round on June 18, 2024.
Who are the main investors in Rarity Bioscience?
Key investors in Rarity Bioscience include Navigare Ventures, Uppsala University Invest.
Will Rarity Bioscience IPO soon?
No public IPO plans have been announced for Rarity Bioscience.
How can I track Rarity Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Rarity Bioscience's shares on secondary markets.